Crossref
A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients
AME Medical Journal · 2024-09 · 9 · 24-24
DOI: 10.21037/amj-23-188 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Medical Journal, 2024-09. Verfasst von Robert Hsu und 1 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hsu, R., & Nieva, J. J. (2024). A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients. AME Medical Journal, 9, 24-24. https://doi.org/10.21037/amj-23-188
Vancouver
Hsu R, Nieva JJ. A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients. AME Medical Journal. 2024;9:24-24. doi:10.21037/amj-23-188
BibTeX
@article{Hsu2024,
author = {Hsu, Robert and Nieva, Jorge J.},
title = {A narrative review of the efficacy and safety FDA-approved antibody-drug conjugates in older patients},
journal = {AME Medical Journal},
year = {2024},
volume = {9},
pages = {24--24},
doi = {10.21037/amj-23-188}
}
EUVIMED